Amgen, Amazon.Com Inc. Share Losses Lead Dow's 288-Point Drop

Dow Jones11-15 23:46

DJ Amgen, Amazon.Com Inc. Share Losses Lead Dow's 288-Point Drop

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is declining Friday morning with shares of Amgen and Amazon.com Inc. delivering the stiffest headwinds for the blue-chip average.

The Dow (Dow Jones Industrial Average) was most recently trading 288 points, or 0.7%, lower, as shares of Amgen (Amgen Inc.) and Amazon.com Inc. (Amazon.com Inc.) are contributing to the blue-chip gauge's intraday decline.

Amgen's shares have dropped $13.99 (4.7%) while those of Amazon.com Inc. have declined $6.20, or 2.9%, combining for an approximately 124-point drag on the Dow.

Merck (Merck & Co. Inc.), undefined (NVIDIA Corp.), and Microsoft (Microsoft Corp.) are also contributing significantly to the decline.

A $1 move in any one of the 30 components of the benchmark results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 15, 2024 10:46 ET (15:46 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment